AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP) clinical study have been enrolled and treated at PinnacleHealth CardioVascular Institute in Harrisburg, Pennsylvania. The study is the first of its kind in the United States for the treatment of persistent or longstanding persistent forms of atrial fibrillation (Afib).

Infraredx announced it will premiere the Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter featuring Extended Bandwidth IVUS technology at the American College of Cardiology’s 2015 Annual Scientific Meeting in San Diego, March 14-16.

Women veterans who had specialized heart tests were younger and more likely to be obese, depressed and suffer from post-traumatic stress disorder than male veterans, according to a study published in an American Heart Association journal.

Toshiba America Medical Systems Inc.’s Dose Tracking System makes interventional procedures safer for patients by measuring peak radiation skin dose during the exam. To expand clinical applications, Toshiba is introducing enhancements to DTS for the entire Infinix product line, including the Elite, Select and Essential cardiovascular X-ray systems.

Men with benign prostatic hyperplasia (BPH), have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, according to research presented at the Society of Interventional Radiology's (SIR's) Annual Scientific Meeting.

Pablo Uceda, M.D., vascular surgeon with DFW Vascular, Dallas, Texas, was successful in using a new device to clear blood clots out of a patient's legs.

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth Adams, M.D., of Penn State Hershey Children's Heart Group, can predict that a child born today has a 90 percent chance of living to adulthood, even with severe CHD.